LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 83.42 | 770.25 | 6338 | 12031 | 0.5268 | 0.7015 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 83.42 | 770.25 | 6114 | 12031 | 0.5082 | 0.6861 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 83.42 | 770.25 | 6840 | 12031 | 0.5685 | 0.7345 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 85.64 | 770.25 | 6664 | 12287 | 0.5424 | 0.7160 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 85.64 | 770.25 | 6327 | 12287 | 0.5149 | 0.6939 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 85.64 | 770.25 | 7169 | 12287 | 0.5834 | 0.7477 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 87.86 | 770.25 | 6835 | 12543 | 0.5449 | 0.7200 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 87.86 | 770.25 | 6465 | 12543 | 0.5154 | 0.6964 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 87.86 | 770.25 | 7440 | 12543 | 0.5931 | 0.7566 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 3.21 | 770.25 | 779 | 904 | 0.8611 | 0.0499 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 3.21 | 770.25 | 985 | 904 | 1.0888 | 1.8865 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 5.44 | 770.25 | 877 | 1012 | 0.8660 | 0.3892 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 5.44 | 770.25 | 1081 | 1012 | 1.0674 | 1.3592 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 7.66 | 770.25 | 934 | 1090 | 0.8569 | 0.4693 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 7.66 | 770.25 | 1132 | 1090 | 1.0385 | 1.1568 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 10.06 | 770.25 | 947 | 1218 | 0.7772 | 0.3664 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 10.06 | 770.25 | 1210 | 1218 | 0.9930 | 0.9790 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 12.28 | 770.25 | 1004 | 1358 | 0.7393 | 0.3825 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 12.28 | 770.25 | 1273 | 1358 | 0.9373 | 0.8479 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 14.50 | 770.25 | 1067 | 1497 | 0.7126 | 0.4047 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 14.50 | 770.25 | 1396 | 1497 | 0.9324 | 0.8592 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 16.73 | 770.25 | 1135 | 1664 | 0.6819 | 0.4173 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 16.73 | 770.25 | 1417 | 1664 | 0.8513 | 0.7304 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 18.95 | 770.25 | 1072 | 1832 | 0.5850 | 0.3026 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 18.95 | 770.25 | 1329 | 1832 | 0.7252 | 0.5469 | MN20160304_L02 | I16 |